Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic epitope tag that enables sensitive detection and efficient purification of HA-tagged proteins in molecular biology workflows (APExBIO product page). The HA peptide's high solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) ensures compatibility with various buffers and conditions. Its function relies on specific, competitive binding to anti-HA antibodies, facilitating precise elution of fusion proteins during immunoprecipitation (Labpe.com article). Purity exceeding 98% (HPLC/mass spectrometry) supports reproducibility in sensitive protein interaction studies. Proper storage (-20°C, desiccated) is critical for long-term stability and performance (Dong et al., 2025).

Biological Rationale

Epitope tags such as the Influenza Hemagglutinin (HA) Peptide are essential in modern molecular biology for tracking and isolating recombinant proteins. The HA tag comprises a defined nine-amino acid sequence (YPYDVPDYA) originally derived from the human influenza hemagglutinin protein. Its small size minimizes interference with protein folding and function. Use of HA tags streamlines detection, purification, and analysis of fusion proteins, especially in complex biological samples. The high affinity and specificity of anti-HA antibodies underpin the tag's broad utility in immunoprecipitation, western blotting, and affinity chromatography (A-740003.com article). In translational research, such as investigating protein-protein interactions or post-translational modifications (e.g., ubiquitination), the HA tag enables standardized protocols and cross-experiment comparability (Dong et al., 2025).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide acts as a competitive ligand for anti-HA antibodies. In typical workflows, an HA-tagged fusion protein is captured on beads or columns coated with anti-HA antibodies. The free Influenza Hemagglutinin (HA) Peptide is then added to the system. Due to its identical epitope sequence, it competes with the tagged protein for binding sites on the antibody. This competitive displacement releases the HA-tagged protein into solution for further analysis (APExBIO).

The HA peptide's sequence (YPYDVPDYA) was optimized for minimal immunogenicity and structural interference. Its high water solubility and stability in organic solvents (≥100.4 mg/mL in ethanol) facilitate its integration into a wide array of experimental buffers and conditions. The peptide's efficacy is confirmed by its ability to reproducibly elute HA-tagged proteins without denaturing them or introducing contaminants (Labpe.com).

Evidence & Benchmarks

• HA tag peptide enables ≥95% recovery of HA-tagged proteins in immunoprecipitation workflows under native conditions (Dong et al., 2025).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in ultrapure water at 25°C, pH 7.4 (APExBIO product page).
• Purity confirmed by HPLC and mass spectrometry: >98% for each production batch (APExBIO).
• HA peptide-mediated elution preserves protein-protein interaction integrity, enabling downstream analyses such as mass spectrometry or functional assays (Angiotensin-1-2-1-9.com).
• Validated as a benchmark molecular tag in studies of E3 ligase function and cancer metastasis, as demonstrated in NEDD4L/PRMT5 interactome mapping (Dong et al., 2025).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is widely employed as a protein purification tag, an epitope tag for protein detection, and as a competitive elution peptide in immunoprecipitation with anti-HA antibody systems. Its use has accelerated progress in protein-protein interaction studies, especially in the context of signal transduction and post-translational modification research (Peptone-Bacteriological.com). This article extends previous discussions by providing quantitative benchmarks and linking HA tag performance to translational cancer research workflows, as exemplified by NEDD4L/PRMT5 pathway studies.

Despite its versatility, the HA tag approach has boundaries:

Common Pitfalls or Misconceptions

• Not a universal purification strategy: The HA tag requires compatible anti-HA antibodies; it is ineffective with unrelated antibody systems.
• Tag placement matters: N- or C-terminal fusion may affect protein folding or function; context-specific validation is necessary (Labpe.com).
• Not suitable for in vivo therapeutic use: The synthetic peptide is for research use only and is not approved for clinical applications.
• Overuse of HA peptide can saturate antibody binding sites: Excess peptide may interfere with subsequent detection steps if not thoroughly washed (APExBIO).
• Cannot resolve closely related protein isoforms if tags are identical: Orthogonal tagging strategies may be required for complex samples.

Workflow Integration & Parameters

The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) can be seamlessly integrated into workflows requiring the detection, immunoprecipitation, or purification of HA-tagged fusion proteins. A typical protocol involves lysis of cells expressing the fusion protein, capture on anti-HA magnetic beads or antibody columns, washing to remove nonspecific interactors, and elution with a defined concentration of HA peptide (commonly 0.1–1 mg/mL in elution buffer, pH 7.4, at 4°C).

Key parameters for optimal performance include:

• Freshly prepare HA peptide solutions; avoid long-term storage in solution.
• Use buffer conditions compatible with both the peptide and antibody (avoid extreme pH or high denaturant concentrations).
• Store lyophilized peptide desiccated at -20°C to maintain stability and purity.
• Monitor elution efficiency by SDS-PAGE or western blot analysis using anti-HA detection.

This article clarifies the quantitative solubility and purity benchmarks of the APExBIO HA peptide, extending previous reviews (AP24534.com), and provides actionable guidance for integrating the product into advanced interactomics and biomarker discovery pipelines.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide, as supplied by APExBIO, is a validated, high-purity tool for protein detection, immunoprecipitation, and purification. Its robust solubility and competitive binding properties make it an indispensable element in molecular biology and translational research. As workflows in cancer signaling and post-translational modification mapping become more complex, the HA tag peptide will remain central to reproducible, high-throughput interactome studies. Future advancements may further optimize tag-antibody systems for multiplexed protein analysis and clinical translation (Dong et al., 2025).

For more product details, refer to the APExBIO Influenza Hemagglutinin (HA) Peptide A6004 page.